A COMPARATIVE STUDY OF STEREOCHEMICAL EFFECTS OF ANTI-PROSTATE AGENTS BY MOLECULAR DOCKING
DOI:
https://doi.org/10.22159/ajpcr.2018.v11s2.28587Keywords:
Stereoisomer, Molecular docking, Anti-prostate agent, AutoDock Vina, AndrogenAbstract
Objective: A comparative study of anti-prostate agents to investigate the stereochemical influences on binding affinity by molecular docking.
Methods: Structures of enantiomers (R and S stereoisomers) for known anti-prostate cancer (PCa) agents were drawn using ChemBioDraw 2D software. Thereafter, they were converted to 3D structures using the ChemBioDraw 3D software in which they were subjected to energy minimization using the MM2 method and then saved as PDB extension files which can be accessed using the ADT interface. AutoDock Vina (ADT) 1.5.6 software version was used for molecular docking study.
Results: A total of 12 different anti-PCa agents were selected and drawn including well-known drug R-bicalutamide. All molecules showed the binding affinity with respect to the nature of stereochemistry. R-stereoisomers showed better interaction as well as binding affinity toward 1z95 (mutated androgen receptor protein involved in the progression of PCa) whereas their S-stereoisomers were found inferior in comparison.
Conclusion: This study showed that CB1-R and R-bicalutamide (with R-stereochemistry) were better in binding affinity comparative to their counterpart CB1-S and S-Bicalutamide (with S-stereochemistry). All the selected anti-PCa agents were showing the effect of stereochemical center; therefore, we must choose the right kind of stereochemistry while planning to develop the newer anti-PCa agents.
Downloads
References
Guyton AC, Hall JE. Textbook of Medical Physiology. 11th ed. Philadelphia, PA: W.B. Saunders; 2006. p. 996-9.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
Dumitrescu R, Cotarla I. Understanding breast cancer risk-where do we stand in 2005? J Cell Mol Med 2005;9:208-21.
Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 2000;10:1595-600.
Volk RJ, Hawley ST, Kneuper S, Holden EW, Stroud LA, Cooper CP, et al. Trials of decision aids for prostate cancer screening: A systematic review. Am J Prev Med 2007;5:428-34.
Kolvenbag GJ, Iversen P, Newling DW. Antiandrogen monotherapy: A new form of treatment for patients with prostate cancer. Urology 2001;58:16-22.
Kaur P, Khatik GL. Advancements in non-steroidal antiandrogens as potential therapeutic agents for the treatment of prostate cancer. Mini Rev Med Chem 2016;16:531-46.
Hutt AJ, Grady JO. Drug chirality: A consideration of the significance of the stereochemistry of antimicrobial agents. J Antimicrob Chemother 1996;37:7-32.
McConathy J, Owens MJ. Stereochemistry in drug action. Prim Care Companion J Clin Psychiatr 2003;5:70-3.
Caldwell J. The importance of stereochemistry in drug action and disposition. J Clin Pharmacol 1992;32:1925-9.
Edlund C, Sjostedt S, Nord CE. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microfiora. Scand J Infect Dis 1997;29:383-6.
Drayer DE. Pharmacodynamics and pharmacokinetic differences between drug enantiomers in humans: An overview. Clin Pharmacol Ther 1986;40:125-33.
Chaurasiya S, Kaur P, Nayak SK, Khatik GL. Virtual screening for identification of novel potent EGFR inhibitors through AutoDock Vina molecular modeling software. J Chem Pharm Res 2016;8:353-60.
Muthukala B, Kanakarajan S, Kamalanathan A. In silico docking of quercetin compound against the HeLa cell line proteins. Int J Curr Pharm Res 2015;7:13-6.
Kaur P, Khatik GL. Identification of novel 5-styryl-1,2,4-oxadiazole/ Triazole derivatives as the potential antiandrogens. Through molecular docking study. Int J Pharm Pharm Sci 2016;8:72-7.
Kaur K, Kaur P, Mittal A, Nayak SK, Khatik GL. Design and molecular docking studies of novel antimicrobial peptides using AutoDock molecular docking software. Asian J Pharm Clin Res 2017;10:28-31.
Bhardwaj S, Khatik GL, Kaur P, Nayak SK. Computer aided drug design through molecular docking: Identification of selective COX-2 inhibitors as potential NSAIDs. J Pharm Res 2017;11:604-8.
Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455-61.
Energy Minimizations were Performed MM2 Interface Program on ChemBio3D Ultra 12.0, and Structures were Drawn by ChemBioDraw Ultra 12.0. Cambridge: Cambridge Soft.; 1985.
1Z95 Protein. Available from: http://www.rcsb.org/pdb/explore. do?pdbId=1z95. [Last accessed on 2017 Oct 22].
Cockshott ID. Bicalutamide: Clinical pharmacokinetics and metabolism. Clin Pharmacokinet 2004;43:855-78.
Bohl CE, Wu Z, Chen J, Mohler ML, Yang J, Hwang DJ, et al. Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators. Bioorg Med Chem Lett 2008;18:5567-70.
Khatik GL, Kaur J, Kumar V, Tikoo K, Venugopalan P, Nair VA. Aldol derivatives of Thioxoimidazolidinones as potential anti-prostate cancer agents. Eur J Med Chem 2011;46:3291-301.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
